Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

As Deadline Passes, Will AstraZeneca plc Attract A New Bid From Pfizer Inc?

| Roland Head

Roland Head asks whether AstraZeneca plc (LON:AZN) still holds the same attraction for Pfizer Inc.

Read more »

Investing Articles

Is It Too Late To Buy November’s Winners, AstraZeneca plc And Vodafone Group plc?

| Harvey Jones

AstraZeneca plc (LON: AZN) and Vodafone Group plc (LON: VOD) have been on a winning streak, Harvey Jones asks whether…

Read more »

Investing Articles

2 Numbers That Could Make AstraZeneca plc A Terrific Turnaround Play

| Royston Wild

Royston Wild explains why AstraZeneca plc (LON: AZN) could prove a classic contrarian winner.

Read more »

Investing Articles

Neil Woodford Praises AstraZeneca plc’s Prospects

| Rupert Hargreaves

Woodford is excited about AstraZeneca plc's (LON: AZN) future prospects.

Read more »

Investing Articles

AstraZeneca plc: Why $4.20 Is The Magic Number

| Rupert Hargreaves

AstraZeneca plc's (LON: AZN) management will be keeping a keen eye on the company's earnings.

Read more »

Investing Articles

Forget About 2015: Why AstraZeneca plc Remains A Spectacular Long-Term Pick

| Royston Wild

Royston Wild explains why AstraZeneca plc (LON: AZN) may prove to be a red-hot growth selection.

Read more »

Investing Articles

At What Price Would AstraZeneca plc Be A Bargain Buy?

| G A Chester

G A Chester explains his bargain-buy price for AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

My Top 3 Pharmaceutical Stocks For 2015: GlaxoSmithKline plc, AstraZeneca plc And BTG plc

| Peter Stephens

GlaxoSmithKline plc (LON: GSK), AstraZeneca plc (LON: AZN) and BTG plc (LON: BTG) could have a great 2015

Read more »

Investing Articles

AstraZeneca plc And GlaxoSmithKline plc Are Strong Buys, But For Very Different Reasons

| Harvey Jones

AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK) have their differences, but there is strength in diversity, says Harvey…

Read more »

Investing Articles

Can AstraZeneca plc Beat The FTSE 100 In 2015?

| Peter Stephens

Should you buy shares in AstraZeneca plc (LON: AZN) in expectation of FTSE 100-beating performance next year?

Read more »

Investing Articles

Will AstraZeneca plc Return To Growth As Soon As Next Year?

| Alan Oscroft

Guidance at AstraZeneca plc (LON: AZN) has been lifted, so how soon will earnings growth follow?

Read more »

Investing Articles

AstraZeneca plc Lifts Full-Year Guidance In Third-Quarter Results

| Peter Stephens

Upbeat quarterly results from AstraZeneca plc (LON: AZN) include an increase in its top and bottom line forecasts for the…

Read more »